SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurocrine Biosciences (NBIX) -- Ignore unavailable to you. Want to Upgrade?


To: Biotech Jim who wrote (763)6/21/2001 9:22:34 PM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 1834
 
Thanks BJ.

MCH, like hypocretins/orexins and some other proteins (my CNS learning curve has serious limitation) are in part contributors of the complex control of energy expenditure.

Because we are talking about MCH-Rx antagonist (which is easy to develop than GPCR agonist) what potential side effects of this antagonist (from receptors CNS distribution and different sub-receptors rules) you foresee?

Miljenko